| Q60548219 | A serologic marker for fetal risk of congenital heart block |
| Q34424622 | Adverse pregnancy outcomes and subsequent risk of cardiovascular disease in women with systemic lupus erythematosus |
| Q72611589 | Anti-La (SS-B) but not anti-Ro52 (SS-A) antibodies cross-react with laminin--a role in the pathogenesis of congenital heart block? |
| Q36711443 | Anti-p57: a novel association with neonatal lupus |
| Q40490976 | Antibody Mediated Complete Congenital Heart Block in the Fetus |
| Q36785747 | Autoantibodies and Pregnancy Wastage |
| Q33356675 | Autoimmune disease in pregnancy |
| Q69493179 | Autoimmune disease in pregnancy |
| Q41519678 | Autoimmune disease in pregnancy. Systemic lupus erythematosus and antiphospholipid syndrome. |
| Q46358042 | Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry |
| Q74144849 | Congenital complete atrioventricular block |
| Q44795490 | Congenital heart block and maternal SLE |
| Q37316414 | Congenital heart block associated with Sjögren syndrome: case report |
| Q34760163 | Congenital heart block in neonatal lupus: the pediatric cardiologist's perspective |
| Q74693232 | Endocardial fibroelastosis associated with maternal anti-Ro and anti-La antibodies in the absence of atrioventricular block |
| Q82216433 | Identification and management of fetuses at risk for, or affected by, congenital heart block associated with autoantibodies to SSA (Ro), SSB (La), or an HsEg5-like autoantigen |
| Q77525394 | Immune-mediated congenital heart block (CHB): identifying and counseling patients at risk for having children with CHB |
| Q73521719 | Increase in the heart rate-corrected QT interval in children of anti-Ro-positive mothers, with a further increase in those with siblings with congenital heart block: comment on the article by Cimaz et al |
| Q41778404 | Investigations into Ro-specific antibody-associated congenital cardiac conduction defects |
| Q36836446 | Left Atrial Inexcitability in Children With Congenital Lupus-Induced Complete Atrioventricular Block |
| Q35119704 | Lupus erythematosus and allied disorders in pregnancy. |
| Q40506568 | Lupus pregnancies and neonatal lupus |
| Q33402503 | Maternal autoantibodies and pregnancy--II: The neonatal lupus syndrome |
| Q34193779 | Maternal issues affecting the fetus |
| Q35118567 | Neonatal Lupus erythematosus Following Rheumatoid Arthritis: Case Report and Literature Review |
| Q34981335 | Neonatal lupus |
| Q73674771 | Neonatal lupus erythematosus |
| Q71510549 | Neonatal lupus erythematosus with congenital heart block and severe heart failure due to myocarditis and endocardititis of the mitral valve |
| Q40520517 | Neonatal lupus erythematosus: a transplacentally acquired autoimmune disorder |
| Q73069257 | Neonatal lupus syndromes |
| Q33360093 | Neonatal lupus: clinical features and management |
| Q33566611 | Obstetric and gynaecological profile in patients with primary Sjögren's syndrome |
| Q79961804 | Outcome of infants from mothers with anti-SSA/Ro antibodies |
| Q38001712 | Pathogenesis of anti-Ro/SS-A autoantibody-associated cutaneous lupus erythematosus. |
| Q41775977 | Perinatal outcome of fetal complete atrioventricular block: a multicenter experience |
| Q38028936 | Pregnancy and rheumatoid disease |
| Q73550790 | Pregnancy in systemic lupus erythematosus |
| Q67470055 | Previous Pregnancy Outcome Is an Important Determinant of Subsequent Pregnancy Outcome in Women With Systemic Lupus Erythematosus |
| Q52865751 | Progressive disease of the atrioventricular conduction axis in an infant of an anti-Ro positive mother. |
| Q37237372 | Resolution of neonatal hypertrophic cardiomyopathy presumed secondary to acquired maternal ribonucleoprotein and smith autoantibodies |
| Q41033561 | Significance of the anti-Ro (SS-A) antibody in evaluation of patients with cutaneous manifestations of a connective tissue disease |
| Q37782039 | Systematic review of the literature informing the systemic lupus erythematosus indicators project: Reproductive health care quality indicators |
| Q40804890 | The clinical implications of autoantibody detection in rheumatology. |
| Q24671851 | The mapping of the human 52-kD Ro/SSA autoantigen gene to human chromosome 11, and its polymorphisms |
| Q90090394 | Use of antenatal fluorinated corticosteroids in management of congenital heart block: Systematic review and meta-analysis |
| Q54030020 | [French register of lupus in pregnancy: the evaluation. Groupe d'étude sur la grossesse lupique]. |
| Q84600029 | [Treatment of systemic lupus erythematosus in the pregnant patient] |